CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 237 filers reported holding CLOVIS ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $19,000 | -40.6% | 1,270 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $32,000 | -68.6% | 1,270 | -77.6% | 0.00% | -75.0% |
| Q4 2018 | $102,000 | -43.6% | 5,670 | -8.1% | 0.00% | -20.0% |
| Q3 2018 | $181,000 | -12.6% | 6,170 | +35.6% | 0.01% | -16.7% |
| Q2 2018 | $207,000 | -11.9% | 4,550 | +2.2% | 0.01% | -25.0% |
| Q1 2018 | $235,000 | -57.0% | 4,450 | -44.7% | 0.01% | -52.9% |
| Q4 2017 | $547,000 | -17.5% | 8,050 | 0.0% | 0.02% | -22.7% |
| Q3 2017 | $663,000 | -12.1% | 8,050 | 0.0% | 0.02% | -4.3% |
| Q2 2017 | $754,000 | +72.9% | 8,050 | +17.7% | 0.02% | +76.9% |
| Q1 2017 | $436,000 | +43.4% | 6,840 | 0.0% | 0.01% | +44.4% |
| Q4 2016 | $304,000 | -58.8% | 6,840 | -14.8% | 0.01% | -67.9% |
| Q3 2015 | $738,000 | +4.5% | 8,030 | -0.6% | 0.03% | +16.7% |
| Q2 2015 | $706,000 | – | 8,081 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |